In the medical sector, documentation often requires precise identification measures to ensure proper patient care and administrative accuracy. One essential tool used for this purpose is the passport size photo maker, which streamlines the process of generating standardized identification photos. For more details, you can explore this link: passport photo maker.
Continue ReadingSandoz’ MS drug receives approval from European Commission
Novartis announced on Tuesday that its Sandoz division, which specializes in generics, has received approval from the European Commission for Tyruko (natalizumab) as a treatment for recurrent forms of multiple sclerosis. Tyruko is the first biosimilar for multiple sclerosis to be approved in Europe and is designed for use in all the indications outlined for […]
Continue ReadingU.S. FDA approves TG Therapeutics’ multiple sclerosis drug; shares surge
TG Therapeutics Inc. announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved its monoclonal antibody for the treatment of relapsing forms of multiple sclerosis (MS), boosting its shares by 47% in afternoon trading. This approval increases the number of available treatments for the disorder to three, offering a potential financial recovery […]
Continue ReadingNovartis loses in patent appeal over multiple sclerosis drug
On Tuesday, a U.S. appeals court ruled that a patent for Novartis AG’s popular multiple sclerosis drug, Gilenya, was invalid, potentially opening the door for the introduction of a more affordable generic version. The U.S. Court of Appeals for the Federal Circuit, which handles patent disputes, reversed its earlier ruling in the case. This decision […]
Continue ReadingRoche warns multiple sclerosis drug development hit by Ukraine war
Roche has raised concerns that Russia’s invasion of Ukraine is hindering the development of new multiple sclerosis (MS) treatments, as the pharmaceutical industry has become increasingly reliant on Eastern Europe for clinical trials. The ongoing conflict has made it challenging for the industry to keep Ukrainian patients enrolled in trials, as millions have fled to […]
Continue ReadingActress Selma Blair’s struggles with MS depicted in new documentary
In October 2018, Selma Blair shared with her fans that she had been diagnosed with multiple sclerosis, a progressive and incurable neurological disease where the immune system attacks the protective sheath of nerve fibers. Her new documentary, *Introducing, Selma Blair*, follows the actress as she navigates life with the condition and undergoes stem cell treatment. […]
Continue Reading